SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052962
Filing Date
2020-11-10
Accepted
2020-11-10 16:10:40
Documents
63
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q phat-10q_20200930.htm 10-Q 1652615
2 EX-10.1 phat-ex101_8.htm EX-10.1 284256
3 EX-31.1 phat-ex311_7.htm EX-31.1 16939
4 EX-31.2 phat-ex312_10.htm EX-31.2 16955
5 EX-32.1 phat-ex321_12.htm EX-32.1 7403
6 EX-32.2 phat-ex322_9.htm EX-32.2 7396
  Complete submission text file 0001564590-20-052962.txt   6814644

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT phat-20200930.xml EX-101.INS 1221390
8 XBRL TAXONOMY EXTENSION SCHEMA phat-20200930.xsd EX-101.SCH 58620
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE phat-20200930_cal.xml EX-101.CAL 45824
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phat-20200930_def.xml EX-101.DEF 229806
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20200930_lab.xml EX-101.LAB 471635
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20200930_pre.xml EX-101.PRE 373955
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39094 | Film No.: 201301213
SIC: 2834 Pharmaceutical Preparations